🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

Recruitingn/aAges 7 Years - 90 YearsAllSecond Affiliated Hospital, Zhejiang University, …
NCT07124572 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * normal participants without eyelid disorders (control group) * patients with thyroid-associated ophthalmopathy (TAO group) * cooperative participants Exclusion Criteria: * participants with pupil or cornea disorders * participants with history of eye injury
💊

What it tests

  • Imaging and ocular examinations
📍

Where

1 site
Juan Ye
Hangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy